Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22025006 | 0.82 | ALDH1A1 (0.31) | CYP2C19 | |
| SCHEMBL15613866 | 0.78 | TAAR1 (0.36) | — | |
| SCHEMBL23957703 | 0.77 | RXRA (0.38) | RXRARXRB | |
| SCHEMBL9927799 | 0.77 | RXRA (0.38) | RXRARXRB | |
| SCHEMBL18950054 | 0.77 | ACHE (0.31) | — | |
| SCHEMBL23136551 | 0.76 | CYP1A2 (0.33) | CYP2C19 | |
| SCHEMBL24140842 | 0.74 | — | — | |
| SCHEMBL23033699 | 0.70 | RXRA (0.35) | RXRARXRB | |
| SCHEMBL9812184 | 0.69 | RXRA (0.32) | RXRARXRB | |
| SCHEMBL9906973 | 0.68 | RXRA (0.39) | RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220064350-A1 | LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING | BASF SE (DE) | 2022-03-03 | — | — | US | disclosed |
| US-20100021831-A1 | TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE | CIBA CORPORATION (US) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064350-A1 | LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING | LIMK1, LIMA1, LIMK2 | RXRA 3175/4885RXRB 3179/4885GRIN2B 2548/4885 |
| US-20100021831-A1 | TRANSPARENT COLOURANTS AND COLOURANT COMPOSITIONS, AND THEIR USE | NDUFA10, STARD10, RPS10 | RXRA 559/4885RXRB 606/4885GRIN2B 2272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.